Transfusion-independent
Showing 1 - 25 of 5,926
Aplastic Anemia Trial in Beijing (Luspatercept)
Not yet recruiting
- Aplastic Anemia
-
Beijing, ChinaPeking union medical college hospital
May 30, 2022
Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))
Active, not recruiting
- Leukemia
- Azacitidine (AZA) Days 1 - 3
- +3 more
-
Tampa, Florida
- +5 more
Jul 21, 2020
Hemorrhage, Trauma, Hypocalcemia Trial (Calcium Gluconate)
Not yet recruiting
- Hemorrhage
- +3 more
- Calcium Gluconate
- (no location specified)
Jul 11, 2023
Hemophilia B Trial in Worldwide (BAX 326 (Recombinant factor IX))
Completed
- Hemophilia B
- BAX 326 (Recombinant factor IX)
-
Rosario, Argentina
- +41 more
Apr 30, 2021
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
Red Blood Cell Transfusion, Oxygen Consumption Trial in Izmir (No intervention group.)
Not yet recruiting
- Red Blood Cell Transfusion
- Oxygen Consumption
- No intervention group.
-
Izmir, TurkeyIzmir Katip Celebi University Ataturk Training and Research Hosp
Mar 22, 2023
MDS Trial in Houston (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2023
Red Blood Cell Transfusion, Anemia, and Necrotizing
Recruiting
- Necrotizing Enterocolitis
- +2 more
- RBC transfusion
- no-RBC transfusion
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Oct 13, 2022
Polycythemia Vera Trial in Worldwide (Pegylated-Proline-interferon alpha-2b, Best available therapy (BAT))
Completed
- Polycythemia Vera
- Pegylated-Proline-interferon alpha-2b
- Best available therapy (BAT)
-
Graz, Austria
- +46 more
May 27, 2021
Transfusion-dependent Thalassemia Trial in Dhaka (Thalidomide Capsules, Placebo)
Recruiting
- Transfusion-dependent Thalassemia
- Thalidomide Capsules
- Placebo
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Oct 18, 2023
Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication Trial (Red Blood Cell Transfusion)
Not yet recruiting
- Blood Loss Anemia
- Extracorporeal Membrane Oxygenation Complication
- Red Blood Cell Transfusion
- (no location specified)
Apr 3, 2023
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Extracorporeal Membrane Oxygenation, Red Blood Cell Transfusion, Organ Failure, Multiple Trial in Canada, United States (Red
Not yet recruiting
- Extracorporeal Membrane Oxygenation
- +2 more
- Red blood cell transfusion
-
Little Rock, Arkansas
- +17 more
Jun 27, 2022
Anemia, Red Blood Cell Transfusion, Fatigability Trial in Chicago (Red blood cell transfusion)
Recruiting
- Anemia
- +4 more
- Red blood cell transfusion
-
Chicago, IllinoisUniversity of Chicago
May 16, 2022
Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)
Not yet recruiting
- Stem Cell Transplant Complications
- Eltrombopag 25 MG Oral Tablet
- Thrombopoietin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 17, 2022
Von Willebrand Disease Trial in Worldwide (Recombinant von Willebrand factor (rVWF), Placebo, Recombinant factor VIIII (rFVIII))
Completed
- Von Willebrand Disease
- Recombinant von Willebrand factor (rVWF)
- +2 more
-
Sacramento, California
- +51 more
Apr 29, 2021
Patient Blood Management in Cardiac Surgery in Turkiye
Recruiting
- Coronary Artery Disease
- Iron Deficiency Anemia
-
Ankara, TurkeyAnkara University School of Medicine Heart Center
Oct 10, 2023
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022